SalaryGuide
AboutPricingFor Employers

Marketing jobs

4 marketing jobs

Indegene logo
2 months ago

Search Engine Optimization Specialist

Indegene

USA (On-site)Full time
Indegene logo
4 months ago

Omnichannel Marketing, Workfront

Indegene

USA (On-site)Full time
Indegene logo
4 months ago

VP, Media Strategy

Indegene

USA (Hybrid)
Indegene logo
5 months ago

Associate Director Media Planning

Indegene

New Hope, PA (On-site)Full time

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

4 jobs
Indegene logo

Search Engine Optimization Specialist

Indegene

USA (On-site)

In-houseFull-timeSenior level8+ years exp.
2 months ago
Indegene logo

Omnichannel Marketing, Workfront

Indegene

USA (On-site)

In-houseFull-timeSenior level7+ years exp.
4 months ago
Indegene logo

VP, Media Strategy

Indegene

USA (Hybrid)

In-houseSenior level7+ years exp.
4 months ago
Indegene logo

Associate Director Media Planning

Indegene

New Hope, PA (On-site)

In-houseFull-timeManager5+ years exp.
5 months ago
Indegene logo
Indegene

Search Engine Optimization Specialist

USA (On-site)

Salary Not AvailableSenior Level8+ years expFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own GEO strategy development and advisory for pharma AI search optimization, translating client goals into actionable roadmaps and measurable business impact across brand, medical, and digital teams.

  • GEO Strategy & Roadmaps: define optimization scope, deliverables, timelines, and pricing with pharma domain credibility.
  • Audit & Maturity: assess AI search readiness and prioritize improvements across content, structured data, and entity authority.
  • Content & Governance Transformation: guide AI-first content workflows and publishing governance to boost LLM discoverability.

Job Description

Responsibilities

  • GEO Strategy & Roadmaps: translate client objectives into GEO strategies and roadmaps for pharma brands and AI ecosystems.
  • Engagement & Workshops: shape engagement strategy, lead client workshops, and ensure pharma-grounded, measurable impact.
  • Audit & Maturity: conduct GEO audits, identify AI search readiness gaps, and define prioritized roadmaps.

Requirements

  • 8+ years in digital strategy, SEO, content strategy, or digital marketing with at least 3+ years in a strategic/consulting role.
  • Minimum 1–2 years in GEO, LLM content strategy, or AI-driven search optimization.
  • Bachelor’s degree in Engineering, Life Sciences, Pharmacy, Marketing, or related field.
  • MBA from a premier institution.

Preferred

  • Certifications in SEO/GEO, Digital Marketing, AI/ML, or Analytics (Google, BrightEdge, Moz, HubSpot, Semrush, Profound) are an advantage.
Indegene logo

Indegene

3.5 Glassdoor

Indegene Limited is the tech-native, life sciences specialist orchestrating the path from commercialization strategy through execution.Trusted by 20 of the world’s top 20 biopharma companies across the value chain — from clinical and medical through commercial — Indegene helps life sciences leaders move at the speed of their ambition with #PractitionerLevelConfidence.Indegene’s difference comes from integrating deep domain knowledge, contextualized technology and operational excellence, built over 25 years. When bold life sciences leaders want to take breakthrough therapies to market faster, maximize impact, and create seamless experiences for patients and physicians, they count on Indegene.

Founded in 1998
Princeton, New Jersey, USA
6.3K employees (1,209 in marketing)
www.indegene.com
65% recommend to a friend
81% CEO approval

Traffic Signals

Monthly Visitors
58K
Monthly Google Ads Budget
$6
Traffic Source Mix
Search
38.1%
Direct
49.4%
Referral
9.7%
Social
2.2%
Paid
0.5%

Headcount Trend

Current headcount: ~6.3K

Marketing Team

Marketing Team Size
794 (13% of company)

Funding

Total Funding
$368.4M
Last Raise
$168.4M
Post IPO Secondary, 10 months ago

Funding History

  • Jun 2025
    Post IPO Secondary • $168.4M
  • Feb 2021
    Private Equity • $200M

Recent News

Is Weakness In Indegene Limited (NSE:INDGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Oct 11, 2025 • simplywall.st
Indegene Expands Precision Pharma Marketing with $104 Million BioPharm Acquisition
Oct 7, 2025 • scanx.trade
Indegene Bets Big On Precision Pharma Marketing With $104 Million BioPharm Acquisition Says ICICI Securities
Oct 7, 2025 • NDTV Profit
Indegene acquires BioPharm to advance AI-driven life sciences marketing
Oct 6, 2025 • PMLiVE
Indegene sees growth tailwinds from digital pharma shift, boosts US presence with BioPharm deal
Oct 3, 2025 • CNBC TV18
Indegene acquires US-based BioPharm to expand AI-led marketing
Oct 2, 2025 • Fortune India
Indegene Limited Prepares for Investor Presentation Amid Strategic Developments
Oct 2, 2025 • TipRanks
Indegene buys BioPharm for $106 mn to boost AI-driven pharma marketing
Oct 2, 2025 • financialexpress.com
Indegene buys BioPharm for $106 million to boost AI-driven pharma marketing
Oct 2, 2025 • Campaign India
Indegene Acquires BioPharm To Strengthen AI-led Commercialisation In Life Sciences
Oct 2, 2025 • BW Marketing World
Indegene acquires BioPharm to boost AI-powered pharma marketing
Oct 1, 2025 • TradingView
Indegene snaps up BioPharm to muscle into AI-powered pharma advertising
Oct 1, 2025 • Indian Television Dot Com
Indegene acquires US-based marketing services agency BioPharm
Oct 1, 2025 • Press Trust of India
Indegene acquires Pennsylvania-based BioPharm
Oct 1, 2025 • Business Standard
Indegene Acquires BioPharm: Expands Marketing Services
Oct 1, 2025 • Rediff MoneyWiz
Indegene Limited Schedules Investor and Analyst Meeting
Oct 1, 2025 • TipRanks
Datavant and Indegene partner to improve trial subject recruitment
Sep 22, 2025 • Clinical Trials Arena
Indegene partners with Datavant to enhance clinical trial recruitment
Sep 20, 2025 • Business Standard
Indegene partners with Datavant to enhance clinical trial recruitment
Sep 20, 2025 • Capital Market
Indegene announces strategic partnership with Datavant
Sep 19, 2025 • Business Standard
The Beat Ideas: Indegene Ltd- The Quiet Tech Player Powering Big Pharma
Sep 16, 2025 • Smartkarma
Indegene Gets Add Rating As ICICI Securities Initiates Coverage
Sep 10, 2025 • NDTV Profit
Indegene rises 3% as ICICI Securities initiates with 'Add'; 14% upside eyed
Sep 10, 2025 • Business Standard
Indegene opens new center in Pune
Sep 6, 2025 • Indian Pharma Post
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25
Aug 21, 2025 • MarketScreener
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25
Aug 21, 2025 • Newsfile
Indegene Limited Shareholders Overwhelmingly Approve IPO Proceeds Reallocation
Aug 13, 2025 • scanx.trade
How Indegene’s AI-powered social intelligence for life sciences turns social media conversations into insights
Aug 12, 2025 • Amazon Web Services
Kotak Securities recommends 'Buy' on this smallcap IT stock; find out why
Aug 12, 2025 • Business Standard India
Indegene Reports 1.8% USD Revenue Growth in Q1, Launches Tectonic Initiative
Aug 6, 2025 • scanx.trade
Indegene posts Q1 net profit higher by 33% YoY to Rs. 116.4 Cr
Aug 6, 2025 • Indian Pharma Post
Indegene Standalone June 2025 Net Sales at Rs 255.60 crore, down 1.16% Y-o-Y
Aug 1, 2025 • Moneycontrol
Indegene Named Leader in Life Sciences AI and Analytics for Commercial PEAK Matrix Assessment 2025 by Everest Group
Aug 1, 2025 • SMEStreet
Indegene Q1 Profit Surges 33% YoY to ₹116.4 Crore
Aug 1, 2025 • India Infoline
India's Indegene gains on quarterly profit rise
Aug 1, 2025 • Reuters
Indegene Q1 net profit climbs 33% on higher revenue, margins
Jul 31, 2025 • CNBC TV18
Indegene Reports 1.8% QoQ Revenue Growth, Unveils Strategic Growth Initiatives
Jul 31, 2025 • scanx.trade
Indegene launches NEXT medical writing automation platform with GenAI
Jul 14, 2025 • BioSpectrum India
Indegene Launches GenAI to Automate Clinical Docs
Jul 14, 2025 • Precedence Research
Indegene launches NEXT Medical Writing Automation
Jul 12, 2025 • Business Standard
Indegene Gets B&Ks Initiation With 15% Upside Projection
Jul 9, 2025 • NDTV Profit
Global Metaverse in Medical Training Market
Jul 8, 2025 • PharmiWeb
Global Pharma Contract Commercialization Market Poised for Steady Growth Driven by Rising Demand for RWE and HEOR Services
Jul 3, 2025 • PharmiWeb
Indegene identified as leader in ISG's Provider Lens for life sciences digital services
Jul 1, 2025 • Indian Pharma Post
Life Sciences Firms Adapt to Change with AI, Partnerships
Jul 1, 2025 • MarketScreener
Life Sciences Firms Adapt to Change with AI, Partnerships
Jul 1, 2025 • Business Wire
U.S. Healthcare Payer Analytics Market Forecast Report 2025-2030, with Profiles of CloudMedx, DataSmart Solutions, Amitech Solutions, IMAT Solutions, Indegene, MedeAnalytics, Verisk Analytics, & more
Jun 23, 2025 • Research and Markets
Coforge, Infosys, TCS: Why are IT stocks rising in trade today? Explained
Jun 16, 2025 • Business Standard India
How Indegene Optimizes User Experience with Amazon CloudWatch | Amazon Web Services
Jun 12, 2025 • Amazon Web Services
Adani Ent, & 19 others to go ex-date on June 13 for dividend, bonus, rights
Jun 12, 2025 • Business Standard India
Carlyle divests entire 10.2% stake in Indegene, realises Rs 1,447 crore
Jun 5, 2025 • financialexpress.com
Carlyle Exits Indegene, Sells ₹1,447 Cr Stake in Bulk Deal
Jun 5, 2025 • HDFC Sky
Sunil Singhania picks stake in Indegene, stock up 4%
Jun 5, 2025 • The Economic Times
Indegene Shares Rise After Block Deals With Eastbridge, Premji Investment, Societe Generale Buy
Jun 5, 2025 • NDTV Profit
Indegene share price jumps 3% as Premji Invest’s affiliate, Societe Generale and others pick stake
Jun 5, 2025 • Livemint.com
Indegene shares slump 4% after block trades; Here's the likely seller
Jun 4, 2025 • Business Standard
Carlyle group exits Indegene; sells 10.2 pc stake for Rs 1,447 cr
Jun 4, 2025 • Press Trust of India
Carlyle group exits Indegene; sells 10.2% stake for Rs 1,447 crore
Jun 4, 2025 • The Economic Times
Indegene Shares Tank 5% After Carlyle Affiliate Likely Exits in Rs 1,504-Cr Block Deal
Jun 4, 2025 • outlookbusiness.com
Indegene block deal: Stock in focus as CA Dawn Investments to sell 10.2% stake today
Jun 4, 2025 • Business Today
Carlyle group exits Indegene; sells 10.2% stake for Rs 1,447 crore
Jun 4, 2025 • Business Standard India
Stocks to watch today, June 4: ABFRL, Indegene, YES Bank, Waaree Renewable
Jun 4, 2025 • Business Standard India
E-commerce giant Flipkart offloads 6% stake in ABFRL; sells 73 mn shares
Jun 4, 2025 • Business Standard India
Top stocks to buy today: Stock recommendations for June 4, 2025
Jun 4, 2025 • IndiaTimes
Indegene Block Deal: Carlyle Group To Exit For At Least Rs 1,420 Crore
Jun 3, 2025 • NDTV Profit
Indegene Block Deal | 10.56% equity worth ₹1,504 crore changes hands, CA Dawn Investments likely seller
Jun 3, 2025 • CNBC TV18
Medical Writing Market Size to Grow at 10.46% CAGR, Globally, by 2030 - Exclusive Report by The Research Insights
Jun 3, 2025 • PR Newswire UK
Medical Writing Market Size to Grow at 10.46% CAGR, Globally, by 2030 - Exclusive Report by The Research Insights
Jun 3, 2025 • PR Newswire
Four block deals worth Rs 3.5k crore today
Jun 3, 2025 • IndiaTimes
Indegene Limited (NSE:INDGN) Annual Results: Here's What Analysts Are Forecasting For This Year
May 3, 2025 • simplywall.st
Indegene Reports Strong Q4 & FY25 Results, Declares Maiden Dividend
Apr 29, 2025 • BW Healthcare World
Pharma cos drifting from point solutions to a platform-based, AI-led approach: Indegene CTO
Apr 2, 2025 • Techcircle
Indegene sees tailwinds in the US, expanding in Europe | Company Business News
Mar 27, 2025 • Mint
Indegene Expands European Footprint with New Center in London
Mar 20, 2025 • eHealth Magazine
Indegene expands presence in Europe, opens new centre in London
Mar 20, 2025 • Express Pharma
Financial Times names Indegene among high-growth companies in Asia-Pacific 2025
Mar 19, 2025 • Indian Pharma Post
Indegene expands presence in Europe; opens new centre in London
Mar 19, 2025 • Pharmabiz.com
Recent 8.3% decline may not have gone down well with Indegene Limited (NSE:INDGN) insiders who've been purchasing recently
Mar 19, 2025 • simplywall.st
Indegene expands presence in Europe with new centre in London
Mar 19, 2025 • BioSpectrum India
Indegene named as winner of Deloitte's Enterprise Growth Awards 2025
Mar 10, 2025 • Business Standard
Indegene Faces Sustained Stock Decline Amid Broader Market Stability Concerns
Feb 25, 2025 • Markets Mojo
Indegene Limited's (NSE:INDGN) Price Is Out Of Tune With Earnings
Feb 25, 2025 • Simply Wall St
Indegene launches Cortex: AI platform for the Life Sciences industry
Feb 25, 2025 • ETHealthWorld
Indegene launches AI platform Cortex
Feb 25, 2025 • Indian Pharma Post
Indegene launched Cortex, a fit-for-purpose Generative AI (GenAI) platform for life science industry
Feb 24, 2025 • Upstox
Indegene launches Gen-AI platform - Cortex
Feb 24, 2025 • Business Standard
Indegene Introduces Cortex, An AI-Powered Platform For Life Sciences
Feb 24, 2025 • BW Healthcare World
Next-Gen AI for Life Sciences? Indegene Just Made It Real with Cortex
Feb 24, 2025 • eHealth Magazine
Indegene launches Cortex for life sciences industry
Feb 24, 2025 • Business Upturn
Indegene IPO subscribed 33 times on Day 3 so far; QIB portion booked over 74x
Feb 23, 2025 • MSN
Indegene Recognized as a Leader in Generative AI Adoption for Life Sciences by Everest Group
Feb 13, 2025 • eHealth Magazine
Indegene launches new entity in Spain
Feb 8, 2025 • Medical Dialogues
Indegene Expands in Europe: What Its New Spain Entity Means for Indian Healthcare
Feb 8, 2025 • eHealth Magazine
Indegene Expands European Presence With New Entity In Spain
Feb 6, 2025 • BW Healthcare World
Indegene Limited appoints Deloitte Haskins & Sells as new statutory auditors for 5 yrs
Jan 31, 2025 • ETLegalWorld.com
CliniOps Announces Strategic Partnership With Indegene to Accelerate Clinical Trials
Jan 9, 2025 • Yahoo Finance
US-based Carlyle group sells 4.3 pc stake in Indegene for Rs 636 crore
Dec 3, 2024 • Press Trust of India
Carlyle Group sells 4.3% in Indegene for ₹636 cr
Dec 3, 2024 • The Economic Times
CA Dawn Investments likely to divest 2.9% stake in Indegene via block deal at ₹615 per share
Dec 2, 2024 • CNBC TV18
Indegene's Stock Price Sees Positive Growth, Outperforms Sector and Market
Nov 25, 2024 • Markets Mojo